Kirsten Franklin, MD
Obstetrics & Gynecology · Suwanee, GANPI 1770547218
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 28.1% of the total. Reporting peaked in 2021 at $886 and has fallen 62.1% since, to $336 in 2025.
Across 202 payments — averaging $19.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Astellas Pharma US Inc$411
- Daiichi Sankyo Inc.$277
- Exeltis, USA Inc.$236
- Evofem Biosciences, Inc.$184
- Baxter Healthcare$180
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,80797%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 57 | $1,098 |
| Astellas Pharma US Inc | 17 | $411 |
| Daiichi Sankyo Inc. | 14 | $277 |
| Exeltis, USA Inc. | 12 | $236 |
| Evofem Biosciences, Inc. | 9 | $184 |
| Baxter Healthcare | 3 | $180 |
| Pfizer | 8 | $164 |
| Agile Therapeutics, Inc. | 8 | $151 |
| Bayer | 10 | $137 |
| Millicent US Inc | 7 | $128 |
| Mayne Pharma Commercial LLC | 6 | $102 |
| Myovant Sciences Inc. | 6 | $95 |
| Therapeuticsmd, Inc. | 5 | $74 |
| Hologic Sales And Service, LLC | 4 | $65 |
| Organon | 6 | $57 |
| Novo Nordisk | 4 | $56 |
| Lupin Inc. | 3 | $51 |
| Merck | 3 | $46 |
| Medtronic | 2 | $46 |
| Phadia US Inc. | 2 | $42 |
| Scynexis, Inc. | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Avion Pharmaceuticals | 2 | $31 |
| Boston Scientific | 1 | $30 |
| Biogen | 1 | $30 |
| Ferring Pharmaceuticals Inc. | 1 | $26 |
| Radius Health, Inc. | 1 | $25 |
| Roche Diagnostics Corporation | 1 | $20 |
| Coopersurgical, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GELFOAM PLUS$149
How this compares
$3,907 in reported general payments places this provider in the 85th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 16 | $1,044 |
| Estradiol | 25 | $671 |
| Fluconazole | 16 | $205 |
| Escitalopram Oxalate | 11 | $125 |
| Trazodone Hcl | 19 | $59 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Suwanee
- Christopher BassilSuwanee$39K
- Courtney MiddletonSuwanee$8K
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
- Tosha Rogers-JonesAtlanta$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.